ALBIREO PHARMA, INC.·4

Jul 25, 4:22 PM ET

Carter Martha J. 4

4 · ALBIREO PHARMA, INC. · Filed Jul 25, 2022

Insider Transaction Report

Form 4
Period: 2022-07-22
Carter Martha J.
Chief Regulatory Officer
Transactions
  • Sale

    Common Stock

    2022-07-22$24.68/sh106$2,61615,668 total
Footnotes (3)
  • [F1]Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.67 to $25.45, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price within the range set forth above.
  • [F3]Represents 1,430 shares of common stock and 14,238 restricted stock units.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION